Kilitch Drugs (India) Ltd Share Price

Pharmaceuticals - Indian - FormulationsNSE
₹223.81
-13.14-5.55% (1D)
As on 20 Nov 2026 at 15:56
As of 20 Nov 2026 at 15:56, Kilitch Drugs (India) Ltd is trading at ₹223.81. The 52-week range stands at ₹117.25–₹267.90, with a market cap of ₹782.09 crore. At a P/E of 27.89 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

KILITCH Price Chart

Market Cap
₹782.09 Cr
PE Ratio
27.89
ROCE
9.42%

Kilitch Drugs (India) Ltd Performance

Kilitch Drugs (India) Ltd Fundamentals

Know More
Market Cap₹782.09 Cr
ROE8.11%
P/E Ratio (TTM)27.89
EPS (TTM)₹8.02
P/B Ratio2.26
Dividend Yield0.00%
Industry P/E91.72
Book Value₹98.92
Debt to Equity0.28
Face Value₹10

Kilitch Drugs (India) Ltd Shareholding Pattern

Know More
Promoter63.8%
Foreign Institutions0.1%
Mutual Funds0%
Domestic Institutions0.5%
Public35.6%

Kilitch Drugs (India) Ltd Financial Statements

Know More
No data for this view.

Kilitch Drugs (India) Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Kilitch Drugs (India)

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions. The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules, liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation. It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America. The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm. The Company launched a new product 'BENIN' in the market in 2011. During the year 2011-12, the Company sold its business located at Paonta Sahib, Himachal Pradesh as a going concern on a slump sale basis along with transfer of services set forth in the Business Transfer Agreement (BTA). The undertaking was sold and transferred on 28th February 2012 after getting all the necessary clearances as indicated in the BTA. It retained its Name, Trademark (Kilitch) and all other properties and assets at Mumbai. It transferred certain products by entering into a Product Transfer Agreement (PTA) with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL. The Company has set up a New Manufacturing Facility at Pen, Maharashtra in 2026.

Parent Organisation—
Founded1992
Managing DirectorMukund P Mehta
NSE SymbolKILITCH

Kilitch Drugs (India) Ltd Resistance and Support levels

R3246.44R2242.17R1239.53S1230.99S2228.35S3224.08223.81

Kilitch Drugs (India) Ltd Technicals

Current Price
₹223.81 ₹13.14 (-5.55%)
Bearish
2
Bullish
10
  • 20 Day2.9%
  • 50 Day6.1%
  • 100 Day11.4%
  • 200 Day17.7%

Kilitch Drugs (India) Ltd Latest News

View More
21 OCT 2026 | Wednesday
Kilitch Drugs (India) confirms Venkita Subramanian Rajan's resignation, effective October 2026

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Annual ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Kilitch Drugs (India) Ltd is ₹223.81 as of 20 Nov 2026 at 15:56.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now